Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report)’s stock price dropped 22.5% on Tuesday . The company traded as low as $0.98 and last traded at $0.98. Approximately 639 shares traded hands during mid-day trading, a decline of 93% from the average daily volume of 9,053 shares. The stock had previously closed at $1.26.
Peak Pharmaceuticals Stock Down 22.5 %
The stock has a 50 day moving average price of $1.03 and a two-hundred day moving average price of $1.94.
Peak Pharmaceuticals Company Profile
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Further Reading
- Five stocks we like better than Peak Pharmaceuticals
- Most active stocks: Dollar volume vs share volume
- 3 Stocks Helping to Bring AI to Healthcare
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
